Why the study?
Does an immunohistochemical panel of PAX2, PAX8, calretinin, and inhibin distinguish intrarenal ectopic adrenal tissue from renal cell carcinoma?
Does an immunohistochemical panel of PAX2, PAX8, calretinin, and inhibin distinguish intrarenal ectopic adrenal tissue from renal cell carcinoma?
A panel of PAX2, PAX8, and inhibin can effectively distinguish benign intrarenal ectopic adrenal tissue from renal cell carcinoma.
Answers are grounded in this paper and cite their sources.
May support IHC distinction of adrenal rests from RCC; leaves open validation in larger prospective series.
BACKGROUND: Adrenal rest (AR) is the presence of ectopic adrenal cortical tissue, often identified incidentally during autopsy (20% of postmortem examination). In the kidney, AR can be found in 6% of the general population. Ectopic adrenal tissue is of no functional significance but may in some cases, pose a diagnostic challenge for the pathologist, especially in the context of renal clear cell renal cell carcinoma (RCC) and small needle biopsies. AIM: To investigate the utility of immunohistochemical stains in distinguishing AR from RCC. METHODS: Archival cases of AR, in our institution, were reviewed and compared with a cohort of RCC cases using a panel of immunohistochemical stains, including PAX2, PAX8, calretinin, and inhibin. RESULTS: Nine of 10 (90%) cases of AR showed positive staining for inhibin and negative staining for calretinin, PAX2 and PAX8. One AR case was positive for PAX2 and PAX8 in addition to inhibin. All (100%) RCC cases were positive for PAX2 and PAX8, but negative for inhibin and calretinin. CONCLUSIONS: A panel of PAX2, PAX8 and inhibin may be useful markers for distinguishing AR from RCC. Calretinin was noncontributory in our study.
No takes yet. Share an insight, caveat, or question.
Yousif et al. (2018) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: